{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-009481","form_type":"8-K","ticker":"MLTX","cik":"0001821586","company_name":"MoonLake Immunotherapeutics","filed_at":"2022-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:04:08.501532+00:00","generated_at":"2026-06-27T04:18:53.619888+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Helix enters $15M convertible loan with MoonLake; rollover option into PIPE","bullets":["Cormorant Private Healthcare Fund IV lends MoonLake $15M interest-free, unsecured, for general corporate purposes pending business combination.","Loan matures 2 days after deal closing or June 30, 2022; may roll over into Cormorant's $27.5M PIPE commitment.","If deal terminates, loan converts into MoonLake shares; subordinated to all creditors but senior to existing subordinated loans.","Proceeds cannot be used to repay existing $15M loan from Biotechnology Value Funds."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-009481","json":"https://secwatch.observer/filing/0001213900-22-009481.json","markdown":"https://secwatch.observer/filing/0001213900-22-009481.md","text":"https://secwatch.observer/filing/0001213900-22-009481.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1821586/000121390022009481/0001213900-22-009481-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1821586/000121390022009481/ea156204-8k_helixacq.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T04:18:53.619888+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}